The ISSCR Encourages Japanese Policymakers to Increase Oversight of Regenerative Medicine Interventions

Written By Keith Alm

The ISSCR sent a letter to Japan’s Ministry of Health, Labour, and Welfare encouraging the Ministry to implement regulations that adhere as closely as possible to international guidelines for the administration of regenerative medicine interventions.

In the letter, shared in response to amendments to the Act on the Safety of Regenerative Medicine (ASRM), the ISSCR commends Japan for taking steps to strengthen the ASRM to protect patient safety and offers recommendations citing this opportunity to strengthen Japan’s approach to regenerative medicine oversight.

Download PDF
Keith Alm
Previous

The ISSCR Files Amicus Brief Supporting FDA’s Authority to Regulate Unproven Stem Cell-Based Interventions
Next

The ISSCR Responds to Ranking Member Cassidy’s Request for Information on NIH Reform